We have significant experience treating not only straightforward abdominal aortic aneurysms (AAA), but those that require complex or hybrid techniques.
Medical Services related to Michael J Shea MD
University of Michigan Frankel Cardiovascular Center Aortic Disease program began in 1995 and has a long history of treating all types of aortic disease.
Our mortality rate for open acute aortic dissection repairs is 5.4 percent over the past 5 years, much less than the national average of 25 percent.
We offer multiple treatments for aortic valve disease, including both open-heart surgery and TAVR for those who are at risk for open surgery.
We treat connective tissue disorders including Marfan's syndrome, Ehlers-Danlos syndrome and Loeys-Dietz syndrome, which can affect the aorta.
University of Michigan Aortic Disease Program treats all kinds of arterial disease, including arteriosclerotic aortic disease (hardening of the arteries).
Patients diagnosed with an enlarged aorta will likely have many questions about the condition: How big is too big? When should I be worried? What does “watchful waiting” mean? Are there any early warning signs before it bursts? Most of the answers to these questions depend on a variety of factors, including age and body size, medical history, and the position and size of the aorta, among others.
The Fenestrated Endograft (FEVAR) is a relatively new minimally-invasive option for people with abdominal aortic aneurysms who don’t qualify for traditional endovascular aneurysm repair (EVAR). The unique feature of fenestrated endografts is that they can cover branch arteries of the aorta (such as the renal arteries) because the graft has fenestrations, or holes, that correspond to the position of the branching arteries within the aorta to allow for blood to flow through the graft into the branch vessel.
Common questions and answers about aortic disease, including aortic valve disease, aortic aneurysms, enlarged aorta, and aortic valve disease. Includes appointment and insurance information.
University of Michigan Thoracic Aortic Program is one of the largest in the country, with low mortality rates for even complex thoracic aortic surgeries.
Thoracic endovascular aortic repair (TEVAR) is a minimally invasive option to conventional open surgery for patients suffering from thoracic aortic aneurysms (TAAs) who are not optimal candidates for traditional open repair. TEVAR can shorten hospital stays and reduce recovery periods. The University of Michigan Frankel Cardiovascular Center’s surgical team has more than two decades of experience performing TEVAR procedures and provides comprehensive care to patients with thoracic aortic aneurysms as well as to all aortic patients, including those who are high-risk.